High serum prolactin levels in men with rheumatoid arthritis

Journal of Rheumatology

Volumn 25, Issue 11, 1998, Pages 2077-2082

  Mateo, Lourdes ^a,b   Nolla, Joan Miquel ^a,c   Bonnin, Maria Rosa ^a,d   Navarro, Miguel Angel ^a,d   Roig Escofet, Daniel ^a,c  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b Rheumatology Service

^c UNIVERSITY OF BARCELONA   (Spain)

^d Hormone Unit

Author keywords

Osteoporosis; Prolactin; Rheumatoid arthritis; Sex hormones

Indexed keywords

ANDROSTENEDIONE; PRASTERONE; PROLACTIN; SEX HORMONE; TESTOSTERONE;

ADULT; AGED; ANDROSTENEDIONE BLOOD LEVEL; BONE DENSITY; BONE MINERAL; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; DISEASE COURSE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; TESTOSTERONE BLOOD LEVEL;

ADULT; AGED; ANDROGENS; ARTHRITIS, RHEUMATOID; BONE DENSITY; DISEASE PROGRESSION; FEMUR; HUMANS; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; OSTEOARTHRITIS; PROLACTIN;

EID: 0031790059     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Reber PM. Prolactin and immunomodulation. Am J Med 1993;95:637-44.
2. Lavalle C. Prolactin A hormone with immunoregulatory properties that leads to new therapeutic approaches in rheumatic diseases. J Rheumatol 1992;19:839-41.
3. Chikanza IC, Panayi GS. Hypothalamic-pituitary mediated modulation of immune function: prolactin as a neuroimmune peptide. Br J Rheumatol 1991;30:203-7.
4. Jara LJ, Lavalle C, Fraga A, et al. Prolactin, immunoregulation, and autoimmune diseases. Semin Arthritis Rheum 1991;20:273-84.
5. Buskila D, Lober M, Neumann L, Flusser D, Shoenfeld Y. No correlation between prolactin levels and clinical activity in patients with systemic lupus erythematosus. J Rheumatol 1996;23:629-32.
6. McMurray RW, Allen SH, Braun AL, Rodriguez F, Walker SE. Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease. J Rheumatol 1994;21:843-50.
7. Lavalle C, Loyo E, Paniagua R, et al. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus. J Rheumatol 1987;14:268-72.
8. Folomeev M, Prokaeva T, Nassonova V, Nassonov E, Masenko V, Ovtraht N. Prolactin levels in men with SLE and RA. J Rheumatol 1990;17:1569-70.
9. Jara-Quezada L, Graef A, Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J Rheumatol 1991;18:349-53.
10. Jara LJ, Lavalle C, Espinoza L. Does prolactin have a role in the pathogenesis of systemic lupus erythematosus? J Rheumatol 1992;19:1333-6.
11. Jara LJ, Silveira LH, Cuéllar ML, Pineda CJ, Scopelitis E, Espinoza LR. Hyperprolactinemia in Reiter's syndrome. J Rheumatol 1994;21:1292-7.
12. Jara LJ, Gómez-Sánchez C, Pineda C, et al. Hyperprolactinemia in reactive arthritis [abstract]. Arthritis Rheum 1991;34 Suppl:D187.
13. McCain G, Tilbe KS. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. J Rheumatol 1989; 16 Suppl 19:154-7.
14. Jara LJ, Gómez-Sánchez C, Espinoza LR. Prolactin in primary fibromyalgia and rheumatoid arthritis. J Rheumatol 1991;18:480-1.
15. Nagy E, Chalmers IM, Baragar FD, Friesen HG, Berczi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991;18:1662-8.
16. Cutolo M, Balleari E, Giusti M, Monachesi M, Accardo S. Sex hormone status in women suffering from rheumatoid arthritis. J Rheumatol 1986;13:1019-23.
17. Berczi I, Cosby H, Hunter T, Baragar F, McNeilly AS, Friesen HG. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis. Br J Rheumatol 1987;26:433-6.
18. Hedman M, Nilsson E, de la Torre B. Low blood and synovial fluid levels of sulphoconjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 1992;10:25-30.
19. Chikanza IC, Oetrou P, Chrousos G, Kingsley G, Panayi GS. Excessive and dysregulated secretion of prolactin in rheumatoid arthritis: immunopathogenetic and therapeutic implications. Br J Rheumatol 1993;32:445-8.
20. Klibanski A, Neer RM, Beitins IZ, Ridgway EC, Zervas NT, McArthur JW. Decreased bone density in hyperprolactinemic women. N Engl J Med 1980;303:1511-4.
21. Greenspan SL, Neer RM, Righway EC, Klibanski A. Osteoporosis in men with hyperprolactinemic hypogonadism. Ann Intern Med 1986;104:777-82.
22. Jackson JA, Kleerekoper M, Parfitt AM. Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism. Ann Intern Med 1986;105:543-5.
23. Klibanski A, Greenspan SL. Increase in bone mass after treatment of hyperprolactinemic amenorrhea. N Engl J Med 1986;315:542-6.
24. Klibanski A, Biller BM, Rosenthal DI, Schoenfeld DA, Saxe V. Effects of prolactin and estrogen deficiency in amenorrheic bone loss. J Clin Endocrinol Metab 1988;67:124-30.
25. Greenspan SL, Oppenheim DS, Klibanski A. Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 1989;110:526-31.
26. Ataya K, Mercedo A, Kartaginer J, et al. Bone density and reproductive hormones in patients with neuroleptic-induced hyperprolactinemia. Fertil Steril 1988;50:876-81.
27. Schlechte JA, Sherman B, Martin R. Bone density in amenorrheic women with and without hyperprolactinemia. J Clin Endocrinol Metab 1983;56:1120-3.
28. Mateo L, Nolla JM, Bonnin MR, Navarro MA, Roig-Escotet D. Sex hormone status and bone mineral density in men with rheumatoid arthritis. J Rheumatol 1995;22:1455-60.
29. Mateo L, Nolla JM, Bonnin MR, Navarro MA, Juanola X, Roig-Escofet D. Prolactin, androgens and bone mineral density in men with rheumatoid arthritis [abstract]. Arthritis Rheum 1994;37 Suppl:S381.
30. Malarkey WB, Hall JC, Pearl DK, Kiecolt-Glaser JK, Glaser R. The influence of academic stress and season on 24 hour concentrations of growth hormone and prolactin. J Clin Endocrinol Metab 1991;73:1089-92.
31. Chikanza IC, Panayi GS. Prolactin secretion in rheumatoid arthritis. Br J Rheumatol 1988;27:324-33.
32. Ostendorf B, Fischer R, Santen R, Schmitz-Linneweber B, Specker Ch Schneider M. Hyperprolactinemia in systemic lupus ervthematosus? Scand J Rheumatol 1996;25:97-102.
33. Pauzner R, Urowitz MB, Gladman DD, Gough JM. Prolactin in systemic lupus erythematosus. J Rheumatol 1994;21:1064-7.
34. Conconi MV, Walker AM. Chloroquine affects prolactin secretion and Golgi morphology in the mammotroph. Endocrinology 1984;114:725-34.
35. Russell DH, Kibler R, Matrisian L, et al. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin binding by cyclosporine. J Immunol 1985;134:3027-31.
36. McMurray RW, Weidensaul D, Allen SH, Walker SE. Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus. J Rheumatol 1995;22:1084-91.
37. Palestine AG, Nussenblatt RB, Gelato M. Therapy for human autoimmune uveitis with low-dose cyclosporine plus bromocriptine. Transplant Proc 1988;20:131-5.
38. Hedner LP, Bynke G. Endogenous iridocyclitis relieved during treatment with bromocriptine. Am J Ophthalmol 1985;100:618-9.
39. Bravo G, Zazueta B, Lavalle C. An acute remission of Reiter's syndrome in male patients treated with bromocriptine. J Rheumatol 1992;19:747-50.
40. Buskila D, Sukenik S, Holcberg G, Horowitz J. Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia. J Rheumatol 1991;18:611-2.
41. Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin? Lancet 1996;348:106-9.
42. Matt KS, Castro L, Yocum DE, Zautra A, Roth S. The effect of stress and flare on neuroendocrine and immune function in rheumatoid arthritis patients [abstract]. Arthritis Rheum 1994;37 Suppl:S46.
43. El-Garf A, Salah S, Shaarawy M, Zaki S, Anwer S. Prolactin hormone in juvenile SLE: A possible relationship to disease activity and CNS manifestations. J Rheumatol 1996;23:374-7.
44. Lawrence JM, Ghosh S, Patrick P, Kaiser FE, Osborn TG, Moore TL. Prolactin deficiency in juvenile rheumatoid arthritis [abstract]. Arthritis Rheum 1993; 35 Supp:S135.
45. Chikanza IC, Petrou P, Kingsley G, Chrousos G, Panayi GS. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992;35:1281-8.
46. Adler RA, Stuffer ME, Gutman J, Brinck-Johnson T. Hypercalciuria and bone changes in male hyperprolactinemic rats. In: McLeod RM, Throner MO, Scapagnini U. Prolactin: Basic and clinical correlates. New York: Springer Verlag;1985:385-9.
47. Pahuja DN, DeLuca HF. Stimulation of intestinal calcium transport and bone calcium mobilization by prolactin in Vitamin D deficient rats. Science 1981;214:1038-9.